Open AccessHepatitis C Treatment by Nonspecialist Providers in the Direct-acting Antiviral Era
Author(s) -
Shashi N Kapadia,
Patricia A. Johnson,
Kristen Marks,
Bruce R. Schackman,
Yuhua Bao
Publication year - 2021
Publication title -
medical care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.632
H-Index - 178
eISSN - 1537-1948
pISSN - 0025-7079
DOI - 10.1097/mlr.0000000000001573
Subject(s) - medicine , discontinuation , medical prescription , odds ratio , pharmacy , regimen , propensity score matching , hepatitis c , retrospective cohort study , hepatitis c virus , family medicine , immunology , virus , pharmacology
Hepatitis C virus (HCV) remains under-treated in the United States and treatment by nonspecialist providers can expand access. We compare HCV treatment provision and treatment completion between nonspecialist and specialist providers.